Table 1. Demographic characteristics.
| PVP (n = 176) | HoLEP (n = 162) | P-value | |
|---|---|---|---|
| Age | 70.7 ± 8.1 | 69.5 ± 7.4 | 0.093 |
| Preop PSA (ng/mL) | 2.0 ± 1.8 | 1.9 ± 1.9 | 0.300 |
| Prostate size by TRUS (mL) | 30.2 ± 6.1 | 29.2 ± 6.7 | 0.091 |
| IPSS total score | 20.4 ± 7.8 | 21.5 ± 8.5 | 0.241 |
| IPSS voiding score | 12.1 ± 5.2 | 13.2 ± 5.4 | 0.057 |
| IPSS storage score | 8.3 ± 3.8 | 8.3 ± 4.3 | 0.940 |
| IPSS QoL | 4.1 ± 2.2 | 4.2 ± 1.1 | 0.640 |
| Qmax (mL/s) | 8.7 ± 4.9 | 9.3 ± 4.3 | 0.174 |
| PVR (mL) | 133.0± 115.7 | 86.8 ± 116.3 | <0.001 |
Values are means ± standard deviation. PVP, photoselective vaporization of prostate; HoLEP holmium laser enucleation of the prostate; PSA, prostate-specific antigen; IPSS, International Prostate Symptoms Score; QoL, quality of life; Qmax, urinary peak flow rate; PVR, post-voiding residual urine.